Search

everythinglearnresearchcommunity

for

Search:↓

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

CD90 is abundantly present on stem-like cells in dog hair follicles.

CD4+ lymphocytopenia can occur in patients with systemic lupus erythematosus.

A new one-step test can quickly identify skin cancer during surgery.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

The humanized AA mouse model is better for testing new alopecia areata treatments.

Activating TLR9 helps heal large wounds and regrow hair by involving a specific type of immune cell.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

ETS2 is crucial in squamous cell carcinoma development and could be a therapeutic target.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

Lymphocytes may hinder hair stem cells, causing hair loss without scarring.

CDK4 levels affect the number of hair follicle stem cells in mice.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Alopecia areata is linked to reduced T cell function and auto-immunity.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Removing certain hair follicle stem cells worsens skin reactions to allergens.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.